We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

70 hedge funds and large institutions have $69.2M invested in Amicus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

401% more call options, than puts

Call options by funds: $1.66M | Put options by funds: $331K

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
70
Increased
–
Reduced
–
Closed
–
Calls
$1.66M
Puts
$331K
Net Calls
+$1.33M
Net Calls Change
+$1.33M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$13.2M +$17.4M +5,653,029 New
PAI
2
Palo Alto Investors
California
$10.8M +$14.2M +4,622,230 New
RIM
3
RS Investment Management
California
$5.88M +$7.75M +2,522,419 New
RG
4
Redmile Group
California
$5.53M +$7.3M +2,373,687 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$3.31M +$4.37M +1,422,696 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.96M +$3.91M +1,271,322 New
UBS AM
7
UBS AM
Illinois
$2.9M +$3.82M +1,244,200 New
BFA
8
BlackRock Fund Advisors
California
$2.86M +$3.77M +1,225,659 New
TC
9
TFS Capital
Pennsylvania
$2.83M +$3.74M +1,216,769 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.55M +$3.36M +1,092,697 New
RA
11
Royce & Associates
New York
$1.67M +$2.2M +715,700 New
SEP
12
Sound Energy Partners
Connecticut
$1.45M +$1.92M +623,500 New
BBA
13
Baker Bros. Advisors
New York
$1.2M +$1.58M +515,072 New
PI
14
Putnam Investments
Massachusetts
$1.05M +$1.38M +450,000 New
State Street
15
State Street
Massachusetts
$1M +$1.32M +429,689 New
Northern Trust
16
Northern Trust
Illinois
$993K +$1.31M +426,498 New
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$932K +$1.23M +400,000 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$864K +$1.14M +370,861 New
BIT
19
BlackRock Institutional Trust
California
$802K +$1.06M +344,034 New
JP Morgan Chase
20
JP Morgan Chase
New York
$634K +$835K +271,811 New
Renaissance Technologies
21
Renaissance Technologies
New York
$405K +$534K +173,644 New
First Manhattan
22
First Manhattan
New York
$364K +$471K +153,300 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$346K +$456K +148,500 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$345K +$455K +148,061 New
DCM
25
Driehaus Capital Management
Illinois
$314K +$414K +134,593 New
1
2 3

FOLD Hedge Fund Activity: Q2 2013 in Review

70 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2013, worth a combined $69.2M.

Buyers outnumbered sellers: 70 funds opened new FOLD positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

  • 70 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $69.2M of Amicus Therapeutics stock for Q2 2013.
  • 70 funds opened new Amicus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +70 holders.

Based on aggregated 13F filings for Q2 2013.